AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery

Recruitingn/aAges 18 Years - 120 YearsAllPopulation Health Research Institute
💬

In plain words

What the trial is, and whether it could suit you

This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Had undergone noncardiac surgery within the past 72 hours and requiring, or expected to require, at least one of the following: * an overnight hospital admission after surgery * day surgery that would result in a large enough physiological insult to be able to cause POAF. Procedures excluded include those that are conducted using local anesthesia alone, are less than 30 minutes in duration, and/or are judged to be of low physiologic insult by the local investigator. 2. Have one of the following high-risk criteria; * age 55-64 years, and having either established cardiovascular disease, recent major vascular surgery, a CHA2DS2-VASc score ≥3, or an elevated postoperative troponin level; * age 65-74 years, and having either established cardiovascular disease, recent major vascular surgery, a CHA2DS2-VASc score ≥2, or an elevated postoperative troponin level; or * age ≥75 years; 3. Provide written informed consent to participate. Exclusion Criteria: 1. History of documented chronic (i.e., non-transient) AF before noncardiac surgery; 2. Need for long-term systemic anticoagulation; 3. Ongoing need for long-term dual antiplatelet treatment; 4. Contraindication to oral anticoagulation; 5. Severe renal insufficiency; 6. Severe liver cirrhosis; 7. Acute stroke in the past 14 days; 8. Underwent cardiac surgery in the past 35 days; 9. History of nontraumatic intracranial, intraocular, or spinal bleeding; 10. Hemorrhagic disorder or bleeding diathesis; 11. Known life expectancy \<1 year due to concomitant disease; 12. Women who are pregnant, breastfeeding, or of childbearing potential not taking effective contraception; 13. Expected to be non-compliant with follow-up and/or device use; 14. Known contact allergy to monitoring device and/or its peripheral components; 15. Previously enrolled in DETECT-POAF.
💊

What it tests

  • Cardiac monitoring device
📍

Where

6 sites
Hamilton General Hospital
Hamilton, Canada
St. Joseph's Healthcare Hamilton
Hamilton, Canada
Juravinski Hospital
Hamilton, Canada
London Health Sciences Centre - University Hospital
London, Canada
Niagara Health System - St. Catharine's Site
St. Catharines, Canada
Hôpital Fleurimont du Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy